Synopses & Reviews
This book provides an introduction to the principles of both cardiovascular epidemiology and molecular pathophysiology; as a unique aspect, it also outlines and discusses the molecular concepts underlying epidemiological observations. This second volume is focused on all aspects concerning "secondary risk factors" in terms of diseases associated with enhanced risk for cardiovascular events. The book promotes the use of interdisciplinary approaches in the field of preventive medicine based on recent advances in molecular and cellular pathophysiology. The book offers a valuable resource work for researchers in basic biomedical fields and clinical scientists alike, as well as guidelines for novel avenues of research in both basic pathophysiology and cardiovascular therapy and prevention
Synopsis
This book is aimed at introduction of the principles of both cardiovascular epidemiology and molecular pathophysiology including the unique aspect of outlining and discussing molecular concepts underlying epidemiological observations. Thereby it promotes and stimulates interdisciplinary concepts in the field of preventive medicine based on recent knowledge in molecular and cellular pathophysiology. This title is intended to serve as a knowledge base for both researchers in basic biomedical fields as well as clinical scientists and as a guideline towards novel avenues for research in both basic pathophysiology and cardiovascular therapy and prevention.
Synopsis
Introducing the principles of both cardiovascular epidemiology and molecular pathophysiology, this book promotes and stimulates interdisciplinary concepts in preventive medicine based on recent research results in molecular and cellular pathophysiology.
About the Author
Prof. Dr. (MD, PhD) Ichiro Wakabayashi, Department of Environmental and Preventive Medicine, Hyogo College of Medicine, Japan Prof. Dr. Klaus Groschner, Associate Professor, Department of Pharmaceutical Sciences, Pharmacology and Toxicology, University of Graz, Austria
Table of Contents
Hypertension and vascular dysfunction.- Obesity and diabetes.- Hyper- and dyslipoproteinemias.- Hyperuricemia.- Proteomics towards biomarkers discovery and risk assessment.